Plasma HDL cholesterol and risk of myocardial infarction¶
Voight. (2012). Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. The Lancet, 6736(12).
Cited by¶
1 citation across 1 artifact.
Each citation links to the sentence it supports in the citing article.
Domain-specific¶
- Natural Experiment
- But Mendelian-randomization analyses (Voight and colleagues, 2012) used a genetic variant that raises HDL and found carriers had no lower risk of heart attack — evidence that some HDL-raising mechanisms do not lower risk, so raising HDL cannot be assumed to reduce it.
This sourceVoight and colleagues' Mendelian-randomisation test of the HDL-raising LIPG Asn396Ser variant, whose carriers showed no reduction in myocardial-infarction risk (OR 0.99, 95% CI 0.88-1.11) despite higher HDL - the paper's own conclusion being that some HDL-raising mechanisms do not lower risk and that raising HDL will not uniformly reduce it.
- But Mendelian-randomization analyses (Voight and colleagues, 2012) used a genetic variant that raises HDL and found carriers had no lower risk of heart attack — evidence that some HDL-raising mechanisms do not lower risk, so raising HDL cannot be assumed to reduce it.
Verification¶
This reference passed the adversarial substantiation pipeline: it was checked to exist and to support the claim it is attached to. See how references were verified.
Registry ID ref:76b98cd11cf8 · see in the full table